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1  | INTRODUC TION
Aspergillus fumigatus is a ubiquitous and opportunistic filamentous 
fungus that causes life- threatening invasive aspergillosis with a high 
mortality rate in immunocompromised individuals such as bone mar-
row and solid organ transplant recipients (Brown et al., 2012; Kousha 
et al., 2011). The therapeutic options for A. fumigatus infections are 
restricted due to limited antifungal repertoire, severe side effects in 
patients and emergence of drug resistance (Bongomin et al., 2017; 
Robbins et al., 2017). Only four structural classes of antifungal 
drugs (azoles, polyenes, echinocandins, and flucytosine) are used 
in the clinical treatment of fungal infections (Ostrosky- Zeichner 
et al., 2010) and no novel antifungal classes have been discovered 
since 2006 (Denning & Bromley, 2015). Clinical development of 
novel therapeutics is mainly limited to combinations of existing 
drugs, repurposing medications or novel synthetic molecules with 
unknown mechanisms of action (Calderone et al., 2014). Thus, these 
problems highlight the importance of identifying and characterizing 
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Abstract
Aspergillus fumigatus is an opportunistic mold responsible for severe life- threatening 
fungal infections in immunocompromised patients. The cell wall, an essential 
structure composed of glucan, chitin, and galactomannan, is considered to be a 
target for the development of antifungal drugs. The nucleotide sugar donor GDP- 
mannose (GDP- Man) is required for the biosynthesis of galactomannan, glyco-
sylphosphatidylinositol (GPI) anchors, glycolipid, and protein glycosylation. Starting 
from fructose- 6- phosphate, GDP- Man is produced by the sequential action of the 
enzymes phosphomannose isomerase, phosphomannomutase (Pmm), and GDP- 
mannose pyrophosphorylase. Here, using heterokaryon rescue and gene knockdown 
approaches we demonstrate that the phosphomannomutase encoding gene in A. fu-
migatus (pmmA) is essential for survival. Reduced expression of pmmA is associated 
with significant morphological defects including retarded germination, growth, re-
duced conidiation, and abnormal polarity. Moreover, the knockdown strain exhibited 
an altered cell wall organization and sensitivity toward cell wall perturbing agents. By 
solving the first crystal structure of A. fumigatus phosphomannomutase (AfPmmA) 
we identified non- conservative substitutions near the active site when compared to 
the human orthologues. Taken together, this work provides a genetic and structural 
foundation for the exploitation of AfPmmA as a potential antifungal target.
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new antifungal targets against A. fumigatus in order to feed into drug 
discovery pipelines.
The fungal cell wall is a complex and highly dynamic structure 
that is essential for cellular morphology and protection against 
environmental stresses and is considered to be a potential drug 
target. It is primarily composed of the polysaccharides chitin, glu-
can, and galactomannan (Gow et al., 2017; Latge et al., 2005). In A. 
fumigatus, galactomannan is a highly complex structure containing 
different types of glycosidic linkages, produced by several manno-
syltransferases (Lee & Sheppard, 2016). As an active form of man-
nose, GDP- mannose is not only required for biosynthesis of fungal 
galactomannan, but also plays an important role in biosynthesis of 
O- and N- linked glycoproteins, glycosylphosphatidylinositol (GPI) 
anchors and glycolipids (Latge et al., 2017; Onoue et al., 2018). 
GDP- mannose biosynthesis is catalyzed by a cascade of three en-
zymes, starting from fructose 6- phosphate (Fru- 6P), converted to 
mannose 6- phosphate (Man- 6P) by mannose 6- phosphate isom-
erase (Pmi), isomerized to mannose 1- phosphate by phospho-
mannomutase (Pmm), and finally converted to GDP- mannose in 
the presence of GTP by GDP- mannose pyrophosphorylase (Gmp) 
(Sharma et al., 2014). Pmm, the second enzyme in GDP- mannose 
biosynthesis, belongs to the haloalkanoic acid dehalogenase 
(HAD) superfamily, containing a conserved phosphorylated motif 
DxDx(T/V) and utilizing a bisphosphate sugar (either glucose 
1,6- bisphosphate or mannose 1,6- bisphosphate) as a co- factor 
(Allen & Dunaway- Mariano, 2004; Collet et al., 1998). Published 
crystal structures of Pmm from Homo sapiens, Leishmania mexicana, 
and Candida albicans revealed conserved overall structures with a 
similar catalytic mechanism of this enzyme family (Ji et al., 2018; 
Kedzierski et al., 2006; Silvaggi et al., 2006). Since GDP- mannose 
is a key metabolic intermediate for many cellular processes, Pmms 
have been identified and genetically characterized in eukaryotes. 
For example, Saccharomyces cerevisiae Pmm was shown to be es-
sential for cell viability under in vitro laboratory conditions (Kepes 
& Schekman, 1988). Similar findings were observed in Arabidopsis 
thaliana, where failure of obtaining the pmm deletion and knock-
down mutants indicated pmm essentiality. Reduced expression 
of pmm leads to a decrease in levels of the antioxidant ascorbic 
acid (AsA) and protein glycosylation (Hoeberichts et al., 2008). 
Mutants of pmm in the protozoan parasite L. mexicana are viable 
but avirulent (Garami et al., 2001). Furthermore, defects in H. sapi-
ens Pmm2 result in a congenital disorder of glycosylation type 1a 
(CDG- 1a), known as Jaeken syndrome, and early embryonic lethal-
ity whereas loss of Pmm1 is not implicated in any known pathol-
ogy (Cromphout et al., 2006; Grunewald, 2009; Thiel et al., 2006; 
Westphal et al., 2001).
Antifungal drug development has historically been impeded 
by evolutionary similarities between fungi and their human host. 
Thus, characterizing the biological functions and structural prop-
erties of potential drug targets is an essential prerequisite for ra-
tional design of novel inhibitors (Hu et al., 2007). Structure- based 
drug discovery has been developed rapidly in the last two de-
cades. Particularly, with the emergence of fragment- based drug 
discovery (FBDD) (Erlanson et al., 2016), it is possible to identify 
weakly binding small fragments (usually molecular mass < 300 Da) 
targeting binding sites away from highly conserved active sites. 
These fragments can be converted to potent inhibitors with high 
selectivity by iterative optimization based on structural and en-
zymological information (Scott et al., 2012). To date, although 
the function of phosphomannomutase has been well character-
ized in many eukaryotes, the physiological function of PmmA in 
the human opportunistic pathogen A. fumigatus remains unclear. 
Moreover, active site sequence conservation of this enzyme fam-
ily with the human orthologues hampers the development of 
specific inhibitors. Here, we demonstrate that AfPmmA is indis-
pensable for viability, morphogenesis, and cell wall integrity in A. 
fumigatus. Importantly, we reveal potential exploitable differences 
in AfPmmA structure compared to its human orthologues. This 
work forms the basis for the initiation of structure- based inhibitor 
design against AfPmmA.
2  | RESULTS
2.1 | A. fumigatus possesses a functional 
phosphomannomutase
Using the Genbank accession codes of H. sapiens Pmm1 
(NP_002667.2) and Pmm2 (NP_000294.1) for a BLASTp search 
in A. fumigatus A1163 genome yielded a single putative phos-
phomannomutase (AfPmmA, EDP49225.1) corresponding to the 
pmmA gene (AFUB_072510). A. fumigatus pmmA is located on 
chromosome 6 and 1,087 bp in length containing four exons and 
three introns. The encoded protein AfPmmA contains 245 amino 
acids with 49% and 53% identity to human Pmm1 and Pmm2, 
respectively. AfPmmA is predicted to catalyze the conversion 
of mannose- 6- phosphate (Man- 6P) to mannose- 1- phosphate 
(Man- 1P) in the synthesis pathway of GDP– mannose (GDP- Man), 
which is the precursor for fungal cell wall mannan biosynthesis 
(Jin, 2012). To determine whether AfPmmA possesses phospho-
mannomutase activity, we overexpressed AfPmmA (residues 
12– 269) as a GST fusion protein in Escherichia coli yielding 8 mg 
per liter of pure AfPmmA after GST- tag cleavage and purifica-
tion. Phosphomannomutases have been reported to use either 
Glc- 1P or Man- 1P as substrates (Pirard et al., 1999a, 1999b). To 
detect AfPmmA activity we used a coupled assay using glucose- 
6- phosphate dehydrogenase, phosphoglucose isomerase, and 
phosphomannose isomerase (for Man- 1P) or glucose- 6- phosphate 
dehydrogenase (for Glc- 1P) as coupling enzymes (Figure 1a). Our 
data showed that AfPmmA had a Km of 86 ± 11 µM for Glc- 1P and a 
Km of 26 ± 5 µM for Man- 1P (Figure 1b,c). Compared to HsPmm1 (Km 
for Glc- 1P and Man- 1P being 5.8 ± 0.8 µM and 54 ± 2 µM, respec-
tively) (Silvaggi et al., 2006), AfPmmA is more selective for Man- 1P. 
However, AfPmmA was 5- fold less catalytically efficient for Glc- 1P 
(kcat/Km = 0.086 µM
– 1 s– 1) than HsPmm1 (kcat/Km = 0.38 µM
– 1 s– 
1). The catalytic efficiency for Man- 1P (kcat/Km = 0.054 µM
– 1 s– 1) 
     |  3ZHANG et Al.
was comparable to HsPmm1 (kcat/Km = 0.081 µM
– 1 s– 1) (Table 1). 
Like other eukaryotic phosphomannomutases, AfPmmA requires 
glucose- 1,6- bisphosphate (Glc- 1,6- bisP, a phosphorylation activa-
tor) and Mg2+ for activity (Allen & Dunaway- Mariano, 2004; Qian 
et al., 2007) (Figure 1d). Taken together, these data suggest that A. 
fumigatus possesses a functional phosphomannomutase.
2.2 | AfpmmA is essential for A. fumigatus viability 
in vitro
To investigate the role of pmmA in A. fumigatus, we attempted to 
construct a null mutant using the Neurospora crassa pyr- 4 selecta-
ble marker to replace the open reading frame of AfpmmA by ho-
mologous recombination (Figure 2a). However, we failed to obtain 
any positive transformants, suggesting that AfpmmA may be es-
sential for growth under in vitro laboratory conditions. To further 
confirm essentiality of AfpmmA, a heterokaryon rescue technique 
was employed (Osmani et al., 2006). As shown in Figure 2b, all 
heterokaryons were not viable on selective media (YAG) but were 
able to grow on nonselective (YUU) media. Moreover, PCR anal-
ysis showed that these heterokaryons contained both wild type 
and deleted alleles (Figure 2c), indicating that pmmA is an essential 
gene in A. fumigatus which is consistent with previous studies in 
S. cerevisiae and Kluyveromyces lactis (Kepes & Schekman, 1988; 
Staneva et al., 2004). As an alternative strategy, we constructed a 
conditional inactivation mutant by replacing the native promoter 
of the pmmA gene with the Aspergillus nidulans alcohol dehydro-
genase promoter (PalcA) that is inducible by ethanol, glycerol, or 
threonine and repressed by glucose (Romero et al., 2003). Over 
fifty transformants were obtained and genotyped. The correct 
F I G U R E  1   Kinetic analysis of recombinant Aspergillus fumigatus phosphomannomutase (AfPmmA). (a) Schematic illustrations of 
AfPmmA assays. Phosphoglucomutase assay: coupled assay with glucose- 6- phosphate dehydrogenase (G6PDH) using Glc- 1P as substrate. 
Phosphomannomutase assay: coupled assay with A. fumigatus phosphomannose isomerase (Pmi) and phosphoglucose isomerase (Pgi) using 
Man- 1P as substrate. (b,c) Kinetic parameters of AfPmmA catalyzed conversion of Glc- 1P to Glc- 6P (b) or Man- 1P to Man- 6P (c) in 50 mM 
HEPES pH 7.1, 5 mM MgCl2, 0.25 mM NADP
+ by monitoring NADPH production. 10 μM Glc- 1,6- bisP was used as cofactor. The results are 
the mean ± SD for three determinations. (d) Effect of Glc- 1,6- bisP, EDTA and metal ions on AfPmmA activity. The metal ions were added at 
5 mM concentration and the activities were measured using 200 μM Glc- 1P as substrate. Control indicates 10 μM Glc- 1,6- bisP and 5 mM 
Mg2+ were added but without addition of EDTA or other metal ions
(a) (b)
(c) (d)










































































Km:  86 ± 11 µM
Km:  26 ± 5 µM







Man- 1P WT AfPmmA 1.4 26 ± 5 0.054
HsPmm1 4.4 54 ± 2 0.081
AfPmmA D25N n.d. n.d. n.d.
AfPmmA D27N n.d. n.d. n.d.
Glc- 1P WT AfPmmA 7.4 86 ± 11 0.086
HsPmm1 2.9 7.5 ± 0.8 0.38
AfPmmA D25N 0.03 48 ± 9 0.0006
AfPmmA D27N 0.03 79 ± 11 0.0004
Note: Data shown is the mean ± SD of three determinations, n.d. 
represents not detectable. The kinetics data of HsPmm1 were obtained 
from (Silvaggi et al., 2006).
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conditional mutant was confirmed by diagnostic PCR and Southern 
blot (Figure S1). Both the wild type and AfpmmA conditional mutant 
(referred to as PalcA::pmmA) displayed similar growth under induc-
ing condition using minimal media (MM) supplemented with 0.1 M 
glycerol, 0.1 M ethanol, or 0.1 M threonine as carbon sources. In 
contrast, hyphal growth of PalcA::pmmA was completely inhibited 
on YEPD and CM, suggesting that expression of pmmA is required 
for A. fumigatus viability (Figure 3a). The growth of PalcA::pmmA 
was partially inhibited on MM containing 1% and 2% glucose (w/v) 
and 0.1 M threonine (Figure 2a). Quantitative PCR was utilized to 
determine the knockdown level of PalcA::pmmA under partial re-
pression and full induction conditions. The mRNA level of pmmA 
was identical compared to that of the wild type under inducing 
condition (MM with 0.1 M threonine [MMT]) and reduced to 56% 
of the wild type level under partial repression condition (MM 
with 0.1 M threonine and 1% glucose [MMTG], Figure 3b). Under 
MMTG, expression of pmmA was reduced to a minimum level that 
supports sufficient mycelia for subsequent experiments. Taken to-
gether, these data suggest that pmmA is essential for A. fumigatus 
viability in vitro.
2.3 | pmmA is required for morphogenesis in 
A. fumigatus
When grown under solid MMTG the radial hyphal growth of the 
PalcA::pmmA conditional strain was decreased to approximately 
45% of that of the wild type at each time point investigated, in-
dicating in vitro growth was affected by the repression of pmmA 
(Figure 4a). Apart from this, the PalcA::pmmA conditional strain 
also showed reduced conidiation under repressive conditions 
(Figure 4b). We next used differential interference contrast (DIC) 
microscopy to examine the edges of the colonies under inducing 
and repressing conditions. An abnormal morphological phenotype 
of hyper- branching at the hyphal tips was observed when pmmA is 
repressed (Figure 4c).
To further explore the effect of pmmA repression in A. fumiga-
tus, the germination rate and pattern were investigated under the 
repressing condition. The PalcA::pmmA conditional strain displayed 
8 hr delayed germination comparing to the wild type (Figure 5a). 
Moreover, a defective germination pattern was observed for the 
PalcA::pmmA conditional strain with 22% morphological abnormalities 
F I G U R E  2   Heterokaryon rescue 
analysis of AfpmmA deletion strains. 
(a) The scheme of construction of 
the AfpmmA deletion strain. (b) After 
transformation with pmmA deletion 
cassette, conidia from six primary 
transformants were streaked onto 
selective (YAG) and nonselective (YUU) 
plates and grown for 48 hr at 37°C. (c) 
Heterokaryons were verified by diagnostic 
PCR. The wild- type only contains the 
wild- type allele (S, 987 bp, primers P19/
P20) and that the all six heterokaryons 
contain both wild- type (S, 987 bp, primers 
P19/P20) and deletion alleles (D, 1708 bp, 
primers P21/P22)
YUU                 YAG
WT
D    S D    S D    S D    S D    S D    S D    S
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in loss of polarity and a high frequency of apical branching at hyphal 
tips (Figure 5b,c) whereas 92% of the wild type cells formed a single, 
straight germ tube and 8% forming two germ tubes (n = 200). Taken 
together, these results suggest that repression of pmmA results in 
a pronounced defect in polarity establishment that is required for 
hyphal growth and asexual development. Thus, pmmA is required for 
morphogenesis in A. fumigatus.
2.4 | AfpmmA expression affects A. fumigatus cell 
wall organization and secreted protein glycosylation
Previous studies demonstrated that enzymes involved in sugar nu-
cleotide biosynthetic pathways are required for cell wall integrity in 
fungi. For example, deficiency of UDP- N- acetylglucosamine pyroph-
osphorylase (Uap1) (Fang et al., 2013b), N- acetylphosphoglucosamine 
mutase (Agm1) (Fang et al., 2013a), phosphoglucose isomerase (Pgi) 
(Upadhyay & Shaw, 2006; Zhang et al., 2015), UDP- glucose pyroph-
osphorylase (Ugp) (Li et al., 2015), Phosphomannose isomerase 
(PMI) (Fang et al., 2009), and GDP- mannose pyrophosphorylase 
(Gmp) (Jiang et al., 2008) lead to the alteration of cell wall compo-
nents and cell wall deficiency. We investigated the role of AfPmmA 
in maintaining cell wall integrity by examining the sensitivity of the 
PalcA::pmmA conditional mutant toward cell wall perturbing agents 
such as Calcofluor White (CFW), Congo red (CR), and Caspofungin. 
CFW and CR interfere with the cell wall structure by inhibiting the 
enzymes involved in connecting chitin to β- 1,3- glucan and β- 1,6- 
glucan (Ram & Klis, 2006) whereas Caspofungin inhibits the synthe-
sis of β- 1,3- glucan (Kahn et al., 2006). Repression of pmmA caused 
hypersensitivity of the PalcA::pmmA conditional mutant to CR and 
CFW but did not alter sensitivity to Caspofungin (Figure 6a) whereas 
no change in sensitivity was observed under conditions inducing 
pmmA expression (Figure 6b). Moreover, the conidiation defect and 
susceptibility to CR and CFW of the PalcA::pmmA conditional mutant 
can be significantly rescued by the addition of osmotic stabilizers 
(1.2 M sorbitol and 0.6 M KCl) to the repression medium, suggest-
ing defects in cell wall integrity under pmmA repression conditions 
(Figure S2). Next, to test whether the phenotypic defects with cell 
wall perturbing agents were due to changes in the cell wall, we exam-
ined hyphal cell wall ultrastructure of wild type and the PalcA::pmmA 
mutant by transmission electron microscopy (TEM). As shown in 
Figure 6c,d, the PalcA::pmmA conditional mutant showed a much 
thinner cell wall compared to the wild type under repressing con-
ditions. In contrast, no difference was observed between the wild 
type and conditional mutant with the induction of pmmA expres-
sion (Figure 6c,d). Moreover, we quantified the individual cell wall 
F I G U R E  3   Growth phenotype of 
the PalcA::pmmA conditional mutant 
under inducing and repressing growth 
conditions. (a) A series of 10- fold dilutions 
of the indicated strains were inoculated 
at 37°C for 48 hr on YEPD, CM, and MM 
supplemented with 1% and 2% glucose 
(w/v), 0.1 M ethanol, 0.1 M glycerol, 0.1 M 
threonine. (b) Relative transcription level 
of AfpmmA gene under induction (MMT) 
and partial repression (MMTG, MMT with 
1% glucose) conditions. Gene expression 
levels were normalized to the reference 
gene tbp. Error bars indicate mean ± SD 
from three independent experiments. 
Data were analyzed using an unpaired of 
t- test, statistical significance is indicated 
by p values; ns, not significant
(b)
(a)
106     105    104   103                 106       105    104   103 
YEPD                                 CM
MMT + 1% Glucose          MMT + 2% Glucose
106      105    104    103                106      105   104   103
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components of the wild type and PalcA::pmmA mutant strains by high- 
performance ionic chromatography (Francois, 2006). Repression of 
pmmA expression led to the reduction of the galactose and mannose 
content by 56% and 57%, respectively, whereas the amounts of 
chitin and glucan were increased by 47% and 49%, respectively 
(Figure 7a). The cell wall components of the pmmA conditional strain 
F I G U R E  4   Phenotypic characterization of the PalcA::pmmA conditional mutant. (a) 1 x 10
6 conidia from the indicated strains were 
inoculated onto solid partial repression (MMTG) media at 37°C, and colony diameter was measured daily. Data are presented as an average 
for each time points from three replicates ± standard deviation. (b) Quantitative data for the number of conidia of each strain grown on 
indicated medium for 48 hr at 37°C. Data are presented as an average from three replicates ± standard deviation. Data were analyzed using 
an unpaired of t- test, statistical significance is indicated by p values; ns, not significant. (c) Colonial and hyphal morphology of the indicated 











































F I G U R E  5   Conidial germination is affected by repression of AfpmmA. (a) Germination rate of the AfpmmA conditional mutant and the 
wild type. Conidia (1 × 106) were incubated in liquid partial repression (MMTG) media for the time indicated. One hundred conidia for each 
strain were assessed for germination rate and the experiment was performed in triplicate. Values represent the mean ± SD. (b) Germination 
pattern of the PalcA::pmmA conditional mutant and the wild- type conidiospores. 1 × 10
6 conidia of the conditional mutant and the wild type 
were allowed to germinate in liquid partial repression (MMTG) media for 9 hr and 24 hr, respectively. Germination morphology was classified 
(1– 4) as shown in figure. The experiment was performed in triplicate. Values represent the mean ± SD. (c) 1 × 106 conidia from each strain 
were inoculated into 2 ml liquid partial repression (MMTG) medium for the indicated time point at 37°C and examined by differential 
interference contrast (DIC) using Axio Scope A1 (Zeiss). Scale bar represents 20 μm
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were similar to those in the wild type upon induction of pmmA ex-
pression (Figure 7a). As GDP- Man is not only important for cell wall 
integrity but also involved in protein glycosylation, we extracted 
the total and secreted proteins from the wild type and PalcA::pmmA 
conditional mutant to detect protein glycosylation levels by western 
blot using biotinylated Concanavalin A. As shown in Figure 7b, the 
repressed PalcA::pmmA conditional mutant exhibited reduced glyco-
sylation levels in secreted proteins, whereas no significant change 
was observed for intracellular proteins, suggesting that repression 
of AfPmmA leads to a reduction of secreted mannosylated proteins. 
Collectively, these results show that AfpmmA expression affects A. 
fumigatus cell wall organization and secreted protein glycosylation.
2.5 | The AfPmmA crystal structure reveals 
exploitable differences
Our data so far suggest that AfPmmA is a genetically validated an-
tifungal target in A. fumigatus. However, the high sequence conser-
vation to the human orthologues suggests that mechanism- inspired 
inhibitors could elicit toxicity. We next determined the crystal struc-
ture of AfPmmA to find potential exploitable differences compared 
to HsPmm1 and HsPmm2. Purified recombinant AfPmmA from E. coli 
was crystallized in PEG solutions in the presence of Mg2+. Molecular 
replacement and refinement against 2.2 Å synchrotron diffraction 
data yielded a model with statistics as shown in Table 2. The P212121 
asymmetric unit consists of two dimers that have different confor-
mations, with RMSDs of 1.7– 2.7 Å for the four monomers versus 
the structure of HsPmm1 (PDB entry 2FUE, Silvaggi et al., 2006). 
However, superposition of the individual core and cap domains of 
AfPmmA onto the corresponding domains of the HsPmm1 (Silvaggi 
et al., 2006) yields RMSDs < 1.0 Å on Cα atoms. Since there is no 
evidence of half- site reactivity or cooperativity for this enzyme (Ji 
et al., 2018), a single monomer will be used in the description and 
figures herein.
The overall crystal structure of AfPmmA is similar to that of C. 
albicans Pmm (PDB entry 5UE7) (67% sequence identity, RMSD 
of 2.5 Å on 221 Cα atoms) and L. mexicana Pmm (PDB entry 2I54, 
(Kedzierski et al., 2006) (53% sequence identity, RMSD of 1.4 Å on 
221 Cα atoms). The structure is divided into two domains: a core 
Rossman- fold domain (Rao & Rossmann, 1973) comprising five par-
allel β- sheets flanked by seven α- helices (residues 1– 98 and 204– 
263), and a cap domain comprising residues 99– 203. The cap and 
core domains are connected by hinge regions comprising residues 
92– 102 and 193– 199 (Figure 8a). In order to dissect substrate bind-
ing modes, we attempted to soak or co- crystallize AfPmmA with a 
range of substrates including Man- 1P, Man- 6P, and Glc- 1,6- bisP, but 
were unable to obtain any complex. By sequence alignment with 
human phosphomannomutases, the key active site residues in the 
AfPmmA are Asp25 as the catalytic nucleophile and Asp27 as an acid 
F I G U R E  6   Sensitivity of the PalcA::pmmA conditional strain to cell wall perturbing agents. (a,b) The indicated number of conidia were 
inoculated onto solid partial repression (MMTG) (panel a) and induction (MMT) (panel b) media supplemented with different cell wall 
perturbing agents: 100 μg/ml Congo Red (CR), 100 μg/ml Calcofluor White (CFW), and 0.2 μg/ml Caspofungin, and then were incubated 
at 37°C for 48 hr. (c) The transmission electron microscope (TEM) images of the wild type and pmmA conditional mutant hyphae in partial 
repression (MMTG) and induction (MMT) media. Scale bar represents 100 nm. (d) Quantification of the cell wall thickness of the wild type 
and pmmA conditional mutant hyphae from TEM images in respective conditions. Values represent the mean ± SD of 10 sections of different 
hyphae; Data were analyzed using an unpaired of t- test, statistical significance is indicated by p values; ns, not significant
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catalyst in the transfer of the phosphoryl group to the Asp25 nuc-
leophile (Figure S3). To detect whether these residues are required 
for AfPmmA catalytic activity, we performed site- directed muta-
genesis to create two distinct point mutants (D25N and D27N) and 
assessed their kinetic properties. The results showed that catalytic 
efficiency of D25N and D27N for Glc- 1P decreased 87- fold and 130- 
fold, respectively, when compared to wild type AfPmmA (Table 1). 
Enzymatic activity was completely abolished for Man- 1P, suggesting 
that these residues are critical for catalytic activity of AfPmmA. As 
a member of the β- D- phosphohexomutase superfamily a conserved 
aspartate, corresponding to Asp25 in AfPmmA, was proposed as a 
nucleophile to form a transient phosphoenzyme intermediate (Jin 
et al., 2014). However, we did not see crystallographic evidence of 
phosphorylation of Asp25, which is in agreement with the reports 
on human and L. mexicana Pmm structures (Kedzierski et al., 2006; 
Silvaggi et al., 2006). This is likely due to the fact that aspartic acid is 
only transiently phosphorylated during catalysis.
Structural superposition of AfPmmA with the structure of 
HsPmm1 in complex with Man- 1P revealed a high level of similar-
ity, with the amino acids required for substrate binding and cataly-
sis being conserved. While Asp231 and Lys232 in AfPmmA, which 
coordinate the magnesium ion, correspond to Asn218 and Glu219 
in HsPmm1, they are conserved as Asp231 and Lys232 in HsPmm2 
(Figures 8b and S3). Similarly, the active site residue Gln193 in 
AfPmmA is equivalent to Met186 in HsPmm1 and Gln177 in HsPmm2 
(Figures 8c and S3). Although the catalytic machinery of AfPmmA 
and human phosphomannomutases is fully conserved, a close in-
spection of both active site and substrate binding areas reveals that 
the human and fungal phosphomannomutases possess potentially 
exploitable differences (Figure 8d). For instance, Glu28 in AfPmmA 
near the active site is equivalent to Gly22 and Gly15 in HsPmm1 
and HsPmm2, respectively. Residues near the Man- 1P binding site, 
Arg35 and Ala36 in AfPmmA, are equivalent to Gln29 and Lys30 
in HsPmm1 and Gln22 and Lys23 in HsPmm2, respectively. Thus, 
AfPmmA possesses potentially exploitable differences compared to 
the human orthologues.
3  | DISCUSSION
In order to circumvent resistance and treat infections of the opportun-
istic pathogen A. fumigatus, the development of novel antifungals tar-
geting critical cellular components or biological mechanisms is urgently 
needed (Denning & Bromley, 2015). Enzymes participating in fungal 
cell wall biogenesis present attractive drug targets due to their essen-
tial biological roles. For instance, the antifungal drug class echinocan-
dins target β- 1, 3- glucan synthase, a key enzyme essential for cell wall 
integrity. Several lines of evidence suggest that GDP- mannose, the 
donor substrate for biosynthesis of cell wall mannan, O/N- glycans, and 
GPI anchors, plays an important role in fungal growth and development 
F I G U R E  7   Cell wall monosaccharide 
contents and glycosylated proteins of 
the PalcA::pmmA conditional mutant 
compared to the wild type. (a) 1 × 106 
conidia were incubated in 100 ml liquid 
partial repression (MMTG) (left panel) 
and induction (MMT) (right panel) media 
at 37°C for 48 hr. The mycelia were 
harvested and 10 mg dry mycelium 
samples were used for analysis as 
described in Experimental procedures. 
Measurements were performed in three 
independent replicates with six technical 
replicates. Data were analyzed using an 
unpaired of t- test, statistical significance 
is indicated by p values; ns, not significant. 
(b) Western analysis of total proteins and 
secreted proteins from the wild- type 
strain and pmmA conditional mutant using 
a biotinylated ConA antibody. Coomassie 
brilliant blue (CBB) staining was used as 
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(Bernard & Latge, 2001; Bowman & Free, 2006; De Groot et al., 2005). 
However, studies regarding the biological functions and structural 
properties of the enzymes in the GDP- mannose biosynthesis pathway 
are limited. In this study, with the combination of genetic and structural 
characterizations, we propose that the A. fumigatus phosphomanno-
mutase PmmA could be a potential drug target.
Several genetic studies have demonstrated that Pmm is indis-
pensable for viability in many eukaryotes (Hoeberichts et al., 2008; 
Kepes & Schekman, 1988; Staneva et al., 2004). In agreement, het-
erokaryon rescue and phenotypic analysis of a conditional mutant 
employing the alc(A) promoter confirmed that pmmA is an essen-
tial gene in A. fumigatus (Figures 2 and 3). Reduced expression of 
AfpmmA resulted in pleiotropic phenotypes such as retarded vege-
tative growth, decreased conidiation, and abnormal hyphal branch-
ing in A. fumigatus (Figures 4 and 5). Similar phenotypic defects were 
observed in several studies with galactomannan deficiency mutants 
including mannosyltransferases Ktr4/CmsA, Ktr7/CmsB, and GDP- 
mannose transporter GmtA in A. fumigatus (Engel et al., 2012; Henry 
et al., 2019; Onoue et al., 2018). Moreover, the downstream enzyme 
of the GDP- mannose pathway, GDP- mannose pyrophosphorylase 
(Gmp) is also essential for viability of A. fumigatus (Jiang et al., 2008). 
gmp deficiency induced similar phenotypes as the pmmA repression 
mutant with the exception of early germination. A possible explana-
tion is that reduced expression of gmp only affects GDP- mannose 
synthesis, while repression of pmmA mutant may lead to the lim-
itation of UDP- glucose since Pmm is also able to convert Glc- 1P to 
Glc- 6P, the precursor of UDP- glucose. In addition to the defects in 
hyphal growth, AfpmmA conditional mutants exhibited alterations 
of cell wall architecture, decreased galactomannan content, and in-
creased chitin and glucan content under partial repressing conditions 
(Figures 6 and 7). However, the compensatory increased content of 
chitin and glucan is not sufficient to maintain normal hyphae growth 
when AfpmmA is repressed. Supplementation with osmotic stabilizers 
could rescue the conidiation defects and sensitivity toward cell wall 
perturbing agents but not hyphal growth in the pmmA conditional 
mutant, suggesting that the abnormal hyphal growth and polarity 
may not be exclusively due to cell wall integrity defects. Although 
we have not examined intracellular hexose phosphate metabolites 
such as Man- 1P, Man- 6P, GDP- mannose in the AfpmmA conditional 
mutant, A reduction of secreted protein glycosylation was observed 
when AfpmmA is repressed. Moreover, a previous study on A. fumi-
gatus phosphomannose isomerase (Pmi), the enzyme upstream of 
PmmA in GDP- mannose biosynthesis, revealed that deletion of Afpmi 
leads to abnormal intracellular hexose phosphates homeostasis (Fang 
et al., 2009). It is thus possible that the phenotypes observed in the 
AfpmmA deficiency mutant are a consequence of the decreased in-
tercellular pools of GDP- mannose. For instance, increased suscep-
tibility of the AfpmmA conditional mutant to ER stress suggests that 
repression of AfPmmA may globally affect GPI- anchor synthesis 
(Figure S2c), which could lead to defects in the delivery and sorting of 
components required for polarity of hyphal tips.
Microbial virulence results from the interaction between the mi-
crobe and the host, with the host immune response being critical 
for the establishment of infection (Casadevall & Pirofski, 2003). The 
fungal cell wall acts as the outermost barrier mediating interaction 
with the environment and mammalian host cells. The composition 
and structure of the cell wall are critical for the activation of the 
immune response during infection. Previous studies have shown 
that deficiencies in galactomannan and protein O- /N- glycosylation 
results in attenuated virulence and altered host immune response 
(Barreto- Bergter & Figueiredo, 2014). The physiological effects of 
alterations in the cell wall due to AfpmmA repression in the context 
of a host requires further investigation.
Enzyme kinetics of AfPmmA showed that the Mg2+- dependent 
enzyme possesses both phosphoglucomutase and phosphomannom-
utase activity with different rate constants (Figure 1). The reaction 
mechanism of phosphomannomutases has been well characterized 
(Nogly et al., 2013; Seifried et al., 2013). An aspartic acid catalytic 
nucleophile initiates a nucleophilic attack on the phosphoryl group of 
the substrate, generating a phosphoaspartyl intermediate, followed 
by nucleophilic attack of a water molecule on the phosphoaspartyl 
intermediate to regenerate the catalytic Asp (Seifried et al., 2013). 
A Glc- 1,6- bisP cofactor is required for maintaining the active site of 
this family of enzymes in the phosphorylated state (Knowles, 1980). 
In this work, there was no electron density for the phosphoryla-
tion of the AfPmmA active site Asp25, in line with the absence of 
AfPmmA activity in the absence of Glc- 1,6- bisP (Figure 1d).
TA B L E  2   Data collection and structure refinement
AfPmmA
Resolution (Å) 23.0– 2.2 (2.32– 2.20)
Space group P212121
Unit cell (Å) a = 80.5, b = 102.1, c = 137.8
No. of reflections 203,250 (26,985)
No. of unique reflections 56,365 (7,848)
I/σ (I) 5.7 (2.9)
Completeness (%) 98.9 (90.0)
Multiplicity 3.6 (3.4)
Rmerge 0.149 (0.363)





No. of residues 1,041







Note: Data between brackets represent the highest resolution shell.
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Compounds targeting essential genes such as pmmA may have 
substantial toxicity due to evolutionary conserved enzymatic prop-
erties and the high structural similarity with its human orthologues. 
To date, information on inhibitors of this class of enzymes is limited 
to a single report describing the dye Disperse Blue 56 (2- chloro- 1,5- 
diamino- 4,8- dihydroxyanthraquinone) that was identified by virtual 
screening as an aggregating inhibitor of Pseudomonas aeruginosa α- D- 
phosphohexomutase (Pmm/Pgm) (Liu et al., 2004). The high- resolution 
crystal structure of AfPmmA reveals that it shares a fold with other 
members of phosphomannomutase superfamily (Figure 8a). By su-
perposition of the AfPmmA with HsPmm1- Man- 1P complex struc-
ture, we identified that the AfPmmA possesses three non- conserved 
residues near the Mg2+ and Man- 1P binding sites (Figure 8d). With 
the advent of fragment- based drug discovery (Scott et al., 2012) and 
PROTAC (Proteolysis targeting chimera) technology (Zou et al., 2019), 
it is possible to exploit and identify molecules with selectivity based 
on subtle differences in protein structure and even for undrugga-
ble targets. For instance, inhibitors have been developed against 
other enzymes involved in sugar nucleotide biosynthesis, such as N- 
acetylphosphoglucosamine mutase AfAgm1 (Fang et al., 2013a), glucos-
amine 6- phosphate N- acetyltransferase AfGna1 (Lockhart et al., 2020), 
and N- acetylglucosamine pyrophosphorylase Uap1 in A. fumigatus and 
Trypanosoma brucei (Fang et al., 2013b; Urbaniak et al., 2013). Similarly, 
although N- myristoyltransferase (Nmt) from Plasmodium falciparum 
only displays a single residue difference at the active site from human 
Nmt, selective inhibitors have been successfully identified and further 
optimized (Bell et al., 2012; Rackham et al., 2014). Thus, it is possible 
to develop potent selective inhibitors against AfPmmA based on the 
structure differences from human Pmms we presented here.
In conclusion, the genetic and structural analysis of PmmA in A. 
fumigatus reported here suggests that AfPmmA is a potential target 
for the development of antifungal drugs. Future efforts are required 
to discover inhibitors targeting this key enzyme in cell wall biosyn-
thesis that may possess anti- fungal activity.
4  | E XPERIMENTAL PROCEDURES
4.1 | Strains and culture conditions
A. fumigatus Ku80ΔpyrG was the recipient parental strain for generat-
ing the mutants described in this work (da Silva Ferreira et al., 2006). 
F I G U R E  8   Crystal structure of AfPmmA. (a) Overview of the AfPmmA crystal structure. Cap domain and core domain are colored 
in salmon and yellow, respectively. Secondary- structure elements of each domain are colored red (helices) and blue (strands). Mg2+ ions 
are shown as grey spheres. (b,c) Superposition of the Mg2+ binding site (b) and Man- 1P binding site (c) residues in the HsPmm1- Man- 1P 
complex (PBD entry 2FUE, Silvaggi et al., 2006) with the corresponding residues in AfPmmA. Carbon atoms of residues are shown as 
salmon (HsPmm1) and teal (AfPmmA) sticks. Mg2+ ions from HsPmm1 and AfPmmA are colored in salmon and teal spheres, respectively. The 
predicted position of Man- 1P was obtained by superposition with HsPmm1- Man- 1P complex (PBD entry 2FUE, Silvaggi et al., 2006) and 
shown as sticks with yellow carbon atoms. (d) Close- up view of the AfPmmA active site. Conserved residues with HsPmm1 are colored in 
grey, non- conserved substitutions are colored in red. Mg2+ is shown as a green sphere. The predicted position of Man- 1P was obtained by 
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Minimal medium (MM) supplemented with 0.1 M glycerol, 0.1 M 
threonine or 0.1 M ethanol as carbon sources was used to induce 
gene expression. YEPD (2% w/v yeast extract, 2% w/v glucose and 
0.1% w/v peptone) medium and CM (complete medium) were used to 
completely and partially repress gene expression (Armitt et al., 1976; 
d'Enfert, 1996). YAG (2% w/v glucose, 0.5% w/v yeast extract, trace 
elements and 2% w/v agar) and YUU (YAG supplemented with 1.2 g/L 
each of uracil and uridine) were used for heterokaryon rescue assays. 
(Todd et al., 2007). A. fumigatus conidia were grown on minimal me-
dium at 37°C for 48 hr and harvested in sterile water supplemented 
with 0.02% (v/v) Tween 20, and counted in a hemocytometer. Conidia 
were stored in 20% glycerol stock at −80°C for long- term storage or 
in sterile water at 4°C for short term storage.
4.2 | Heterokaryon rescue
Heterokaryon rescue assays were performed as previously de-
scribed (Osmani et al., 2006). Conidia from heterokaryotic primary 
transformants were replica streaked onto selective (YAG) and 
nonselective (YUU) plates for the pyrG marker of the pmm dele-
tion cassette. Heterokaryons were confirmed by diagnostic PCR 
using primer P19/P20 for wild- type alleles and primers P21/P22 
for deletion alleles.
4.3 | Construction of the A. fumigatus pmmA 
conditional inactivation mutant
The pAL3 plasmid (Romero et al., 2003) containing the alcohol de-
hydrogenase promoter (PalcA) and the N. crassa pyr- 4 gene as a fun-
gal selectable marker was used to construct a vector allowing the 
replacement of the native promoter of the pmmA gene by PalcA. The 
fragment from −60 to +957 of the pmmA genomic DNA sequence 
was amplified with primers P7 and P8 (Table S1). The PCR- amplified 
fragment was cloned into the expression vector pAL3 to yield pALP-
mmN and confirmed by sequencing using the University of Dundee 
sequencing service. Generation of protoplasts and polyethylene 
glycol- mediated transformation were performed as previously de-
scribed (Tilburn et al., 1983) and positive transformants were se-
lected for uridine/uracil prototrophy. The transformants were 
confirmed by PCR and southern blotting. For PCR analysis, three 
pairs of primers (P1/P2, P3/P4, and P5/P6) (Table S1) were utilized. 
Primers P1 and P2 were used to amplify a 1,087 bp fragment of the 
pmmA gene. P3 and P4 were used to amplify a 1.59 kb fragment from 
the PalcA to a downstream flanking region of the pmmA gene. Primers 
P5 and P6 were used to amplify the N. crassa pyr- 4 gene. For south-
ern blot, genomic DNA of parental and pmmA conditional strains was 
digested with XbaI, separated by electrophoresis, and transferred 
to a nylon membrane (Zeta- probe+, Bio- Rad). The 800 bp fragment 
of pmmA was used as probe. Labeling and visualization were per-
formed using the DIG DNA labeling and detection kit (Roche Applied 
Science) according to the manufacturer's instructions.
4.4 | Quantitative real- time PCR
Total RNA from A. fumigatus cultured in liquid MM supplemented 
with 0.1 M threonine (MMT) or 1% glucose (MMTG) at 37°C, 
200 rpm for 48 hr was extracted using Trizol reagent (Invitrogen). 
Complementary DNA synthesis was performed with 1.5 μg of RNA 
using the qScript cDNA SuperMix (Quanta bioscience) according to 
the manufacturer's instruction. Primers P9 and P10 were used to 
amplify a fragment of pmmA, and Primers P11 and P12 were used 
to amplify an 80 bp tbp gene (encoding TATA- box- binding protein, 
as a reference gene). Quantitative real- time PCR (qRT- PCR) was car-
ried out with the PerfeCta SYBR Green FastMix (Quanta bioscience) 
using a Rotor- Gene Q real- time PCR system (Qiagen). Thermal cy-
cling conditions were 95°C for 2 min, followed by 45 cycles of 95°C 
for 15 s, and 60°C for 60 s. Real- time PCR data were acquired using 
Sequence Detection software. The standard curve method was used 
to analyze the real- time PCR data. Samples isolated from different 
strains and at different time were tested in triplicate.
4.5 | Analysis of the PalcA::pmmA conditional mutant
To test the sensitivity of the conditional mutant to cell wall perturb-
ing reagents, serial dilutions of PalcA::pmmA and wild- type conidia 
from 105 to 102 were inoculated on MMT or MMTG plates contain-
ing 100 μg/ml Calcofluor White, 100 μg/ml Congo Red and 5 μg/ml 
Caspofungin, respectively. After incubation at 37°C for 48 hr, the 
plates were photographed.
For quantitative determination of cell wall monosaccharides, 
conidia were inoculated into 100 ml MMTG liquid medium at a con-
centration of 106 conidia ml– 1 and incubated at 37°C with shaking at 
200 rpm for 48 hr. The mycelia were harvested, washed with deion-
ized water and stored at −80°C. Fungal cell wall monosaccharides 
were extracted and quantitatively determined as described previously 
(Francois, 2006). For the conidial germination assay, 1 × 106 conidia ml– 
1 were inoculated into 20 ml liquid MMTG containing a single coverslip 
and incubated at 37°C. Germination rate was determined by counting a 
total of 100 spores and noting the number of germinated spores using 
a bright- field microscope at each time point. Counting was repeated 
three times for each strain. Radial growth rate was determined by in-
oculating 104 conidia onto solid MMTG media and recording colony 
diameter daily. For the conidiation assay, 5 μl conidia suspensions (106 
conidia ml– 1) were spotted onto solid MMTG or MMT media and incu-
bated at 37°C for 2 days. Conidia were collected with 0.05% Tween 20 
solution and quantified. Values represent means standard deviations 
(SD) of results from three different experiments.
4.6 | Western blotting
The indicated strains were inoculated into liquid MMTG and cultured at 
37°C, 200 rpm for 48 hr. The mycelia were harvested and ground in liq-
uid nitrogen with a mortar and pestle, then resuspended in lysis buffer 
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(10 mM Tris- HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 
protease inhibitor mixture), and centrifuged at 10,000g for 15 min at 
4°C. Supernatants were collected as total proteins. Secreted proteins 
from culture media were concentrated by acetone precipitation. The 
total and secreted proteins were separated in 12% SDS- PAGE gels and 
then transferred into a polyvinylidene difluoride (PVDF) membrane 
(Millipore). The blots were probed with biotinylated ConA (1:2000, 
Vector Laboratories, B- 1005- 5) and subsequently with horseradish 
peroxidase- conjugated streptavidin (1:1,000, Vector Laboratories, SA- 
5014- 1). Blots were detected by Enhanced ECL luminescence detec-
tion kit (Vazyme, E411), and images were acquired with a Tanon 4200 
chemiluminescent imaging system (Tanon).
4.7 | High- pressure freeze substitution transmission 
electron microscopy
Strains were grown in liquid MMTG or MMT media at 37°C for 24 hr. 
The harvested mycelia were frozen under pressure using a Leica EM 
AFS2 automatic freeze substitution system and EM FSP freeze sub-
stitution processor (Leica Microsystems). The freeze substitution and 
embedding, sectioning, and staining was performed by the Microscopy 
and Histology Facility of the Institute of Medical Sciences, University 
of Aberdeen as described previously (Hall et al., 2013). Samples were 
examined using a Philips CM10 transmission microscope (FEI UK Ltd., 
Cambridge, United Kingdom), and images were captured using a Gatan 
BioScan 792 camera system (Gatan UK, Abingdon, United Kingdom). 
The average thicknesses of cell wall layers were calculated from 10 
measurements for each strain.
4.8 | Cloning of A. fumigatus pmmA
The A. fumigatus pmmA gene (accession no. Q4WNF2) was ampli-
fied by PCR from an A. fumigatus cDNA library using primers P1/P2 
(Table S1) for cloning into plasmid pGEX- 6P1 (GE Healthcare). This 
generated the final expression plasmid pGEX- AfPmmA12- 269 (amino 
acids 12– 269). This vector encodes a glutathione- S- transferase 
(GST) tag followed by a PreScission protease cleavage site. Site- 
direct mutagenesis of D25N and D27N was performed using pGEX- 
AfPmmA12- 269 as the template, P15, P16 and P17, P18 (Table S1) as 
primers following the QuickChange protocol (Stratagene). All plas-
mids were verified by sequencing using the University of Dundee 
sequencing service.
4.9 | Expression and purification of AfPmmA
The N- terminally truncated pGEX- AfPmmA12- 269 and mutated forms 
(D25N, D27N) were transformed into E. coli BL21 (DE3) pLysS and 
cultured in Luria– Bertani (LB) medium supplemented with ampicillin 
(0.1 mg/ml) at 37°C. Then, 10 ml culture was used to inoculate 1 liter 
LB medium and grown to an OD600 of 0.6. Protein expression was 
induced by 250 μM of IPTG (isopropyl- β- D- thiogalactopyranoside) 
and then incubated at 16°C for 18 hr. The cells were harvested by 
centrifugation at 3,500 rpm, 4°C for 30 min. The cell pellet was re-
suspended in 25 ml of ice- cold lysis buffer containing 25 mM HEPES 
pH 7.5, 150 mM NaCl, 10 mg/ml DNase, 0.5 mg/ml lysozyme and a 
tablet of protease inhibitor cocktail (Roche) and lysed using a French 
press at 600 psi. After centrifugation (20,000g, 30 min, 4°C), the 
supernatant was incubated with pre- washed glutathione Sepharose 
4B beads (GE Healthcare) at 4°C on a rotating platform for 2 hr and 
subsequently the GST tag was cleaved with PreScission protease by 
incubating at 4°C for 18 hr. The eluted solution was concentrated to 
5 ml using a 10 kDa cut- off Vivaspin concentrator (GE Healthcare) 
and loaded onto a Superdex 200 column (Amersham Bioscience) 
equilibrated with the same lysis buffer and eluted at a flow rate 
of 1 ml/min. The fractions were concentrated using a 10 kDa cut- 
off Vivaspin concentrator (GE Healthcare) and verified by 10% 
SDS- PAGE.
4.10 | Steady- state kinetics
A. fumigatus PmmA activity was determined via a coupled fluo-
rescent assay as reported previously (Pirard, Achouri, et al., 1999) 
with minor modifications. Briefly, 10 µM glucose- 1,6- bisphosphate 
was used as the co- factor and the reaction mixture was incubated 
at 30°C for 30 min in a buffer consisting of 50 mM HEPES pH 7.1, 
5 mM MgCl2, 0.25 mM NADP
+ and 10 µg/ml glucose- 6- phosphate 
dehydrogenase. Phosphoglucomutase activity was measured in the 
presence of 0 to 500 µM glucose 1- phosphate, and phosphoman-
nomutase activity was measured in the presence of 0 to 300 µM 
mannose- 1- phosphate using 10 µg/ml of phosphoglucose isomer-
ase (Pgi) and 3.5 µg/ml of phosphomannose isomerase (Pmi), re-
spectively. The production of NADPH was determined using a 
SpectraMax i3x (Molecular Devices) with emission at 440 nm and 
excitation at 340 nm. To detect the effects of divalent metal ions 
on AfPmmA activity, 1 mM EDTA and 5 mM each metal ion (Mg2+, 
Ca2+, Mn2+, Zn2+) were added and the activities were measured using 
200 μM Glc- 1P as substrate.
4.11 | Crystallization, data collection, and structure 
determination
Sixteen milligram per milliliters of pure AfPmmA protein in 25 mM 
HEPES buffer, 150 mM NaCl, pH 7.5 was used for crystal screening 
using the sitting drop method. Each drop contained an equal volume 
of 0.2 μl of protein and 0.2 μl of reservoir solution. Crystals grew 
after 3 days from condition C1 of Morpheus Screen HT- 96 (0.09 M 
NPS, 0.1 M MES/Imidazole pH 6.5, 20% v/v PEG500 MME, 10% 
w/v PEG 20,000) (Molecular Dimension). Data were collected on a 
Rigaku Saturn 944 + CCD with a Rigaku MM007 HFM generator 
(wavelength 1.54 Å) at 100 K using 0.25 oscillations for 188 images 
and processed with the HKL suite (Otwinowski & Minor, 1997). The 
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structure was solved by molecular replacement using MOLREP with 
the HsPmm1- Man- 1P complex structure (PDB entry 2FUE, Silvaggi 
et al., 2006) as the search model. REFMAC (Murshudov et al., 1997) 
was used for further refinement and iterated with model building 
using COOT (Emsley & Cowtan, 2004). Figures were produced with 
PyMol (DeLano, 2004). The atomic co- ordinates and structure fac-
tors of AfPmmA were deposited in the Protein Data Bank with ac-
cession code 6I5X.
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